Literature DB >> 24994769

Is the American Society of Shoulder and Elbow Therapists' rehabilitation guideline better than standard care when applied to Bankart-operated patients? A controlled study.

Lars Damkjær1, Tom Petersen2, Birgit Juul-Kristensen3.   

Abstract

OBJECTIVE: To determine whether there is a difference in shoulder-related physical function and quality of life between postoperative rehabilitation patients receiving standard care and those receiving care according to the American Society of Shoulder and Elbow Therapists' rehabilitation guideline for arthroscopic anterior capsulolabral repair of the shoulder.
DESIGN: Descriptive studies with comparison between a retrospective and a prospective cohort.
SETTING: Municipal outpatient rehabilitation centre. PATIENTS: A total of 96 arthroscopic Bankart-operated patients.
INTERVENTIONS: A total of 52 patients received standard care; 44 patients underwent rehabilitation according to the American Society of Shoulder and Elbow Therapists' rehabilitation guideline. MAIN MEASUREMENTS: Primary outcome variable was Western Ontario Shoulder Instability Index. Secondary outcome measures were Patient-Specific Functional Scale, shoulder range of motion, return to work, return to sports, and costs.
RESULTS: There was no significant difference in adjusted mean change scores between the standard care group and the guideline group in the primary outcome variable (Western Ontario Shoulder Instability Index total = 574.85 vs. 644.48) or the secondary outcomes (Patient-Specific Functional Scale = 4.6 vs. 5.0; range of motion in forward flexion = 46.49° vs. 49.58°; external rotation in adduction = 28.58° vs. 34.18°; external rotation in abduction = 51.29° vs. 47.55°; weeks until return to work = 5.2 vs. 6.9; weeks until return to sports =13.9 vs. 13.1; costs = number of visits; 18.5 vs. 15.9).
CONCLUSIONS: There were no significant between-group differences in shoulder-related physical function and quality of life between the standard care group and the guideline group, following Bankart operations.
© The Author(s) 2014.

Entities:  

Keywords:  Bankart; rehabilitation; shoulder

Mesh:

Year:  2014        PMID: 24994769     DOI: 10.1177/0269215514539819

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  A Comparison of Physical Therapy Protocols Between Open Latarjet Coracoid Transfer and Arthroscopic Bankart Repair.

Authors:  Alexander Beletsky; Jourdan M Cancienne; Brandon J Manderle; Nabil Mehta; Kevin E Wilk; Nikhil N Verma
Journal:  Sports Health       Date:  2020-01-09       Impact factor: 3.843

Review 2.  Evolving Concepts in the Management of Shoulder Instability.

Authors:  Steven F DeFroda; Allison K Perry; Blake M Bodendorfer; Nikhil N Verma
Journal:  Indian J Orthop       Date:  2021-03-04       Impact factor: 1.251

3.  Physical Therapy Protocols for Arthroscopic Bankart Repair.

Authors:  Steven F DeFroda; Nabil Mehta; Brett D Owens
Journal:  Sports Health       Date:  2018-01-03       Impact factor: 3.843

4.  Enhanced rehabilitation guidance after arthroscopic capsulolabral repair of the shoulder: a randomized controlled trial.

Authors:  Juhani Multanen; Pauli Kiuru; Kirsi Piitulainen; Jari Ylinen; Juha Paloneva; Arja Häkkinen
Journal:  Clin Rehabil       Date:  2020-05-07       Impact factor: 3.477

5.  Integrated care programmes for sport and work participation, performance of physical activities and quality of life among orthopaedic surgery patients: a systematic review with meta-analysis.

Authors:  Pieter Coenen; Gerben Hulsegge; Joost G Daams; Rutger C van Geenen; Gino M Kerkhoffs; Maurits W van Tulder; Judith A Huirne; Johannes R Anema; P Paul Kuijer
Journal:  BMJ Open Sport Exerc Med       Date:  2020-03-26

Review 6.  Factors That Influence the Return to Sport After Arthroscopic Bankart Repair for Glenohumeral Instability.

Authors:  Luciano Andrés Rossi; Ignacio Pasqualini; Ignacio Tanoira; Maximiliano Ranalletta
Journal:  Open Access J Sports Med       Date:  2022-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.